|
|
||||||||
Original Research Communication |
1 From the International Center for Diarrhoeal Disease Research, Bangladesh (ICDDR,B): Centre for Health and Population Research, Dhaka, Bangladesh (SJMO, MAW, and GJF); the Division of Human Nutrition and Epidemiology, Wageningen University, Wageningen, Netherlands (SJMO and JMAR); the Department of International Health, School of Hygiene and Public Health, The Johns Hopkins Medical Institutions, Baltimore (MS and REB); and the Department of Pediatrics, Louisiana State University School of Medicine, New Orleans (GJF).
Background: Evidence for an effect of zinc supplementation on growth and morbidity in very young infants in developing countries is scarce and inconsistent.
Objective: We assessed the effect of zinc supplementation on growth and morbidity in poor Bangladeshi infants aged 424 wk.
Design: Infants from Dhaka slums were enrolled at 4 wk of age and randomly assigned to receive 5 mg elemental Zn/d (n = 152) or placebo (n = 149) until 24 wk of age. They were followed weekly for information on compliance and morbidity; anthropometric measurements were performed monthly. Serum zinc was assessed at baseline and at 24 wk of age.
Results: At 24 wk of age, serum zinc concentrations were higher in the zinc than in the placebo group (13.3 ± 3.8 and 10.7 ± 2.9 µmol/L, respectively; P < 0.001). Significantly greater weight gains were observed in the zinc than in the placebo group for 43 infants who were zinc deficient (< 9.18 µmol/L) at baseline (3.15 ± 0.77 and 2.66 ± 0.80 kg, respectively; P < 0.04). In the other infants, no significant differences were observed in mean weight and length gains during the study period. Zinc-deficient infants showed a reduced risk of incidence of acute lower respiratory infection after zinc supplementation (relative risk: 0.30; 95% CI: 0.10, 0.92); among the non-zinc-deficient infants there were no significant differences between treatment groups.
Conclusions: Zinc-deficient Bangladeshi infants showed improvements in growth rate and a reduced incidence of acute lower respiratory infection after zinc supplementation. In infants with serum zinc concentrations > 9.18 µmol/L, supplementation improved only biochemical zinc status.
Key Words: Zinc supplementation infants morbidity growth Bangladesh
This article has been cited by other articles:
![]() |
L. L Iannotti, N. Zavaleta, Z. Leon, A. H Shankar, and L. E Caulfield Maternal zinc supplementation and growth in Peruvian infants Am. J. Clinical Nutrition, July 1, 2008; 88(1): 154 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aggarwal, J. Sentz, and M. A. Miller Role of Zinc Administration in Prevention of Childhood Diarrhea and Respiratory Illnesses: A Meta-analysis Pediatrics, June 1, 2007; 119(6): 1120 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L F. Walker, Z. A Bhutta, N. Bhandari, T. Teka, F. Shahid, S. Taneja, R. E Black, and the Zinc Study Group Zinc during and in convalescence from diarrhea has no demonstrable effect on subsequent morbidity and anthropometric status among infants <6 mo of age Am. J. Clinical Nutrition, March 1, 2007; 85(3): 887 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F Krebs and K M. Hambidge Complementary feeding: clinically relevant factors affecting timing and composition Am. J. Clinical Nutrition, February 1, 2007; 85(2): 639S - 645S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J. Heinig, K. H Brown, B. Lonnerdal, and K. G Dewey Zinc supplementation does not affect growth, morbidity, or motor development of US term breastfed infants at 4-10 mo of age. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 594 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Dewey, R. J. Cohen, and K. H. Brown Exclusive Breast-Feeding for 6 Months, with Iron Supplementation, Maintains Adequate Micronutrient Status among Term, Low-Birthweight, Breast-Fed Infants in Honduras J. Nutr., May 1, 2004; 134(5): 1091 - 1098. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |